Johnson & Johnson Q3 Report Singles Out China as Only Country Market Named, With International Surgery Sales Down 4.2%

China was the only country market singled out in Johnson & Johnson's Q3 report. International surgery sales fell 4.2% year over year on an operational basis to $1.459 billion, while U.S. surgery sales grew 3.7%, a 7.9 percentage point gap that dragged global surgery into negative growth. Businesses selling Johnson & Johnson surgical consumables in China will be directly affected.